Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 3,487 INR
Change Today +42.15 / 1.22%
Volume 9.6K
As of 7:06 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

sanofi india ltd (SANL) Snapshot

Open
3,445
Previous Close
3,444
Day High
3,520
Day Low
3,416
52 Week High
11/21/14 - 3,788
52 Week Low
08/11/14 - 2,722
Market Cap
80.3B
Average Volume 10 Days
13.9K
EPS TTM
63.00
Shares Outstanding
23.0M
EX-Date
04/16/15
P/E TM
55.3x
Dividend
34.00
Dividend Yield
1.29%
Current Stock Chart for SANOFI INDIA LTD (SANL)

Related News

No related news articles were found.

sanofi india ltd (SANL) Related Businessweek News

No Related Businessweek News Found

sanofi india ltd (SANL) Details

Sanofi India Limited manufactures and sells pharmaceutical products in India and internationally. It provides medicines for the treatment of patients in various therapeutic areas, such as cardiovascular diseases, thrombosis, diabetes, oncology, respiratory system, central nervous system, dermatology, analgesics, anti-infectives, bone and joint, gastrointestinal disorders, and consumer healthcare. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was founded in 1956 and is based in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

3,448 Employees
Last Reported Date: 03/9/15
Founded in 1956

sanofi india ltd (SANL) Top Compensated Officers

Managing Director, Vice President of South As...
Total Annual Compensation: 8.6M
Chief Financial Officer, Whole-Time Director,...
Total Annual Compensation: 6.1M
Senior Director of Industrial Affairs - India
Total Annual Compensation: 9.8M
Compensation as of Fiscal Year 2013.

sanofi india ltd (SANL) Key Developments

Aventis Pharma Ltd Wins GBP 230 Million Multiple Awardees Contract for Supplying Generic Pharmaceuticals

Aventis Pharma Ltd. won a GBP 230 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of generic pharmaceuticals.

Sanofi India Limited Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015; Approves Final and Special Dividend for the Year Ended December 31, 2014 Payable on May 8, 2015

Sanofi India Limited announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of INR 4,598 million against INR 4,199 million a year ago. Profit from continuing operations before other income and finance costs and exceptional items was INR 570 million against INR 570 million a year ago. Net profit after exceptional items was INR 484 million against INR 517 million a year ago. Net profit after exceptional items was INR 645 million against INR 517 million a year ago. Basic and diluted earnings per share before and after exceptional items were INR 28.04 against INR 22.48 a year ago. The company announced that the annual general meeting held on April 29, 2015, approved a final dividend of INR 24 per Equity share for the year ended December 31, 2014. The dividend will be paid on May 8, 2015. The company also approved special one-time dividend of INR 11 per Equity share of INR 10 for the year ended December 31, 2014.

Sanofi India Limited to Report Q1, 2015 Results on Apr 29, 2015

Sanofi India Limited announced that they will report Q1, 2015 results on Apr 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SANL:IN 3,486.60 INR +42.15

SANL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 4,041 INR 0.00
Cadila Healthcare Ltd 1,882 INR 0.00
Medivation Inc $132.05 USD +0.42
Pfizer Ltd/India 2,217 INR 0.00
Piramal Enterprises Ltd 934.45 INR 0.00
View Industry Companies
 

Industry Analysis

SANL

Industry Average

Valuation SANL Industry Range
Price/Earnings 40.7x
Price/Sales 3.9x
Price/Book 5.3x
Price/Cash Flow 21.0x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI INDIA LTD, please visit www.sanofiindialtd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.